Microbicidal spermicide or spermicidal microbicide?
暂无分享,去创建一个
[1] G. Rahav,et al. Efficacy of a novel pH‐buffering tampon in preserving the acidic vaginal pH during menstruation , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[2] D. Weiner,et al. Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study. , 2001, Contraception.
[3] R. Trager. MICROBICIDES:Raising New Barriers Against HIVInfection , 2003, Science.
[4] F. Uckun,et al. Structural Requirements for Potent Anti-Human Immunodeficiency Virus (HIV) and Sperm-Immobilizing Activities of Cyclohexenyl Thiourea and Urea Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase1 , 2002, Biology of reproduction.
[5] A. Dwivedi,et al. Substituted acrylophenones and related mannich bases as possible spermicides and inhibitors of HIV envelope glycoprotein-CD4 interaction. , 2002, European journal of medicinal chemistry.
[6] K. Whaley,et al. Microbicide Efficacy and Toxicity Tests in a Mouse Model for Vaginal Transmission of Chlamydia trachomatis , 2002, Sexually transmitted diseases.
[7] U. Tamoufé,et al. Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial. , 2002, JAMA.
[8] M. Bergeron,et al. Sodium lauryl sulfate, a microbicide effective against enveloped and nonenveloped viruses. , 2002, Current drug targets.
[9] K. Whaley,et al. Microbicides for preventing transmission of genital herpes. , 2002, Herpes : the journal of the IHMF.
[10] W. Stamm,et al. In Vitro Microbicidal Activities of Cecropin Peptides D2A21 and D4E1 and Gel Formulations Containing 0.1 to 2% D2A21 against Chlamydia trachomatis , 2002, Antimicrobial Agents and Chemotherapy.
[11] G. Doncel,et al. An update on vaginal microbicides , 2001, Current infectious disease reports.
[12] D. Anderson,et al. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. , 2001, The Journal of infectious diseases.
[13] J. Kirby. Nonoxynol-9 may increase HIV transmission risk. , 2001, Positive living.
[14] S. Baron,et al. Practical prevention of vaginal and rectal transmission of HIV by adapting the oral defense: use of commercial lubricants. , 2001, AIDS research and human retroviruses.
[15] B. Richardson,et al. Evaluation of a Low-Dose Nonoxynol-9 Gel for the Prevention of Sexually Transmitted Diseases: A Randomized Clinical Trial , 2001, Sexually transmitted diseases.
[16] F. Uckun,et al. Lack of adverse effects on fertility of female cd‐1 mice exposed to repetitive intravaginal gel–microemulsion formulation of a dual‐function anti‐HIV agent: aryl phosphate derivative of bromo‐methoxy‐zidovudine (compound WHI‐07) , 2001, Journal of applied toxicology : JAT.
[17] Robert A. Anderson,et al. Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM). , 2001, Contraception.
[18] J. Peipert,et al. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] J. H. van de Wijgert,et al. Phase 1 Trial of the Topical Microbicide BufferGel: Safety Results From Four International Sites , 2001, Journal of acquired immune deficiency syndromes.
[20] J. Wijgert,et al. Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. , 2001 .
[21] D. Weiner,et al. Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study. , 2001, Contraception.
[22] M. Cohen,et al. Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus. , 2000, Infectious disease clinics of North America.
[23] F. Uckun,et al. Novel Thiourea Compounds as Dual-Function Microbicides , 2000, Biology of reproduction.
[24] F. Uckun,et al. Evaluation of subchronic (13‐week) and reproductive toxicity potential of intravaginal gel–microemulsion formulation of a dual‐function phenyl phosphate derivative of bromo‐methoxy zidovudine (compound whi‐07) in B6C3F1 mice , 2000, Journal of applied toxicology : JAT.
[25] S. Hillier,et al. Effect of Chlorhexidine on Genital Microflora, Neisseria gonorrhoeae, and Trichomonas vaginalis In Vitro , 2000, Sexually transmitted diseases.
[26] L. Heise,et al. What's up with nonoxynol-9? , 2000, Reproductive health matters.
[27] F. Uckun,et al. Structural Requirements for Potent Human Spermicidal Activity of Dual-Function Aryl Phosphate Derivative of Bromo-Methoxy Zidovudine (Compound WHI-07)1 , 2000, Biology of reproduction.
[28] F. Uckun,et al. Evaluation of subchronic (13 weeks) and reproductive toxicity potential of intravaginal gel-microemulsion formulation of a dual-function phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-05) in B(6)C(3)F(1) mice. , 2000, Contraception.
[29] S. Batra,et al. In search of new chemical entities with spermicidal and anti-HIV activities. , 1999, Bioorganic & medicinal chemistry.
[30] F. Uckun,et al. Prophylactic contraceptives for HIV/AIDS. , 1999, Human reproduction update.
[31] M. Krohn,et al. The effects of three nonoxynol-9 preparations on vaginal flora and epithelium. , 1999, The Journal of infectious diseases.
[32] S. Hillier,et al. Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). , 1999, American journal of obstetrics and gynecology.
[33] F. Uckun,et al. WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity. , 1999, Contraception.
[34] F. Uckun,et al. Synthesis, characterization and preclinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities. , 1999, Molecular human reproduction.
[35] D. Fleming,et al. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. , 1999, Sexually transmitted infections.
[36] C. Dailard. Abortion in context: United States and worldwide. , 1999, Issues in brief.
[37] M. Gigante,et al. Sexually transmitted diseases and reproductive tract infections among contraceptive users , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[38] F. Uckun,et al. Aryl phosphate derivatives of bromo-methoxy-azidothymidine are dual-function spermicides with potent anti-human immunodeficiency virus. , 1998, Biology of reproduction.
[39] H. Ward,et al. Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. , 1998, The Journal of infectious diseases.
[40] D. Taylor-Robinson,et al. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[41] S. Hillier,et al. Effects of Nonoxynol‐9 on Vaginal Microflora and Chlamydial Infection in a Monkey Model , 1996, Sexually transmitted diseases.
[42] C. Lee. Review: in vitro spermicidal tests. , 1996, Contraception.
[43] A. Bhaduri,et al. Synthesis and spermicidal activities of dithiocarbamates , 1996 .
[44] A. Neri,et al. Bacterial vaginosis: drugs versus alternative treatment. , 1994, Obstetrical & gynecological survey.
[45] G. Doncel,et al. Synergistic spermicidal activity of neem seed extract, reetha saponins and quinine hydrochloride. , 1994, Contraception.
[46] Forrest Jd. Timing of reproductive life stages. , 1993 .
[47] J. Forrest. Timing of Reproductive Life Stages , 1993, Obstetrics and gynecology.
[48] T. Fleming,et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. , 1992, JAMA.
[49] S. Niruthisard,et al. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections , 1992, The Lancet.
[50] A. Bruce,et al. Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound nonoxynol-9. , 1992, The Journal of infectious diseases.
[51] S. Klebanoff. Effects of the spermicidal agent nonoxynol-9 on vaginal microbial flora. , 1992, The Journal of infectious diseases.
[52] T. Hooton,et al. Nonoxynol-9: differential antibacterial activity and enhancement of bacterial adherence to vaginal epithelial cells. , 1991, The Journal of infectious diseases.
[53] B. Jones,et al. The susceptibility of organisms associated with bacterial vaginosis to spermicidal compounds, in vitro. , 1991, Genitourinary medicine.
[54] H. Mohri,et al. Spermicidal activity of menfegol‐coated condom , 2009, Andrologia.
[55] P. Piot,et al. Incidence of Uncomplicated Genital Infections in Women Using Oral Contraception or an Intrauterine Device: A Prospective Study , 1990, Sexually transmitted diseases.
[56] M. Wainberg,et al. Inactivation of human immunodeficiency virus type 1 in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride , 1990, Journal of clinical microbiology.
[57] S. Gove,et al. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection. , 1985, JAMA.
[58] B. S. Setty,et al. Screening of Indian plants for biological activity: Part VII--Spermicidal activity of Indian plants. , 1977, Indian journal of experimental biology.
[59] B. S. Setty,et al. Spermicidal potential of saponins isolated from Indian medicinal plants. , 1976, Contraception.
[60] G. Bernstein. Physiological aspects of vaginal contraception a review , 1974 .
[61] G. Bernstein. Physiological aspects of vaginal contraception. , 1974, Contraception.
[62] S. Segal. Fertility regulation. , 1967, The Journal of practical nursing.